CD8A and COVID-19: In the acute phase of COVID-19, SARS-CoV-2-specific CD8+ T cells expressed activation markers (CD38 and HLA-DR) and secreted cytotoxic molecules (perforins and granzyme B), indicating these cells were activated with cytotoxic functions (31).